GPT and metabolic dysfunction-associated steatotic liver disease: The level of ALT and AST can reflect fat accumulation in the liver (32) and decreased AST/ALT is considered a biomarker of nonalcoholic fatty liver diseases (NAFLD), even if its value is within the normal range (33).